Is single-unit blood transfusion bad post-coronary artery bypass surgery?

OBJECTIVES Publications in the surgical literature are very consistent in their conclusions that blood is dangerous with regard to in-hospital mortality, morbidity and long-term survival. Blood is frequently used as a volume expander while simultaneously increasing the haematocrit. We investigated the effects of a single-unit blood transfusion on long-term survival post-cardiac surgery in isolated coronary artery bypass grafting patients. METHODS A prospective single-institution cardiac surgery database was analysed involving 4615 patients. Univariate, multivariate stepwise Cox regression analysis and propensity matching were performed to identify whether a single-unit blood transfusion was detrimental to long-term survival. RESULTS Univariate analysis revealed that blood was significantly associated with a reduced long-term survival even with a single-unit transfused, P = 0.0001. Cox multivariate regression analysis identified age, ejection fraction, preoperative dialysis, logistic EuroSCORE, postoperative CKMB, blood transfusion, urgent operative status and atrial fibrillation as significant factors determining long-term survival. When the Cox regression was repeated with patients who received no blood or only one unit of blood, transfusion was not a risk factor for long-term survival. An interaction analysis revealed that blood transfusion was significantly interacting with preoperative haemoglobin levels, P = 0.02. Propensity analysis demonstrated that a single-unit transfusion is not associated with a detrimental long-term survival, P = 0.3. CONCLUSIONS Cox regression and propensity matching both indicate that a single-unit transfusion is not a significant cause of reduced long-term survival. Preoperative anaemia is a significant confounding factor. Despite demonstrating the negligible risks of a single-unit blood transfusion, we are not advocating liberal transfusion and would recommend changing from a double-unit to a single-unit transfusion policy. We speculate that blood is not bad, but that the underlying reason that it is given might be.

[1]  Joseph P Desimone,et al.  Limited blood transfusion does not impact survival in octogenarians undergoing cardiac operations. , 2012, The Annals of thoracic surgery.

[2]  O. Senn,et al.  Significant reduction of red blood cell transfusion requirements by changing from a double-unit to a single-unit transfusion policy in patients receiving intensive chemotherapy or stem cell transplantation , 2012, Haematologica.

[3]  E. Fontaine,et al.  Does positron emission tomography scanning improve survival in patients undergoing potentially curative lung resections for non-small-cell lung cancer? , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[4]  L. Bond,et al.  Comparing the outcome of on-pump versus off-pump coronary artery bypass grafting in patients with preoperative atrial fibrillation. , 2011, Interactive cardiovascular and thoracic surgery.

[5]  E. Fontaine,et al.  Should we operate on microscopic N2 non-small cell lung cancer? , 2011, Interactive cardiovascular and thoracic surgery.

[6]  R. Luechinger,et al.  Wall stress of the cervical carotid artery in patients with carotid dissection: a case-control study. , 2011, American journal of physiology. Heart and circulatory physiology.

[7]  V. Hasselblad,et al.  Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. , 2011, JAMA.

[8]  L. Bond,et al.  Does off-pump coronary artery revascularization improve the long-term survival in patients with ventricular dysfunction? , 2010, Interactive cardiovascular and thoracic surgery.

[9]  E. Fontaine,et al.  Aspirin and non-small cell lung cancer resections: effect on long-term survival. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[10]  D. Delurgio,et al.  New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft. , 2010, Journal of the American College of Cardiology.

[11]  B. Reeves,et al.  Increased mortality, morbidity, and cost associated with red blood cell transfusion after cardiac surgery , 2008, Current opinion in cardiology.

[12]  Chris A Rogers,et al.  Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery , 2007, Circulation.

[13]  Liang Li,et al.  Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting* , 2006, Critical care medicine.

[14]  M. Kuduvalli,et al.  Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[15]  B. Spiess,et al.  Transfusion of Blood Products Affects Outcome in Cardiac Surgery , 2004, Seminars in cardiothoracic and vascular anesthesia.

[16]  T. Walsh,et al.  Red cell transfusion practice following the transfusion requirements in critical care (TRICC) study: prospective observational cohort study in a large UK intensive care unit , 2003, Vox sanguinis.

[17]  R. Habib,et al.  Effect of blood transfusion on long-term survival after cardiac operation. , 2002, The Annals of thoracic surgery.

[18]  J. Marshall,et al.  Variation in red cell transfusion practice in the intensive care unit: a multicentre cohort study , 1999, Critical care.

[19]  W. C. Sheldon,et al.  Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. , 1986, The New England journal of medicine.

[20]  B. Keszthelyi,et al.  Measurement of blood loss by total-body counting on the basis of calculated and predicted blood volumes. , 1979, Acta medica Academiae Scientiarum Hungaricae.